Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds.

[1]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[2]  H. Westerhoff,et al.  Metabolic control analysis indicates a change of strategy in the treatment of cancer. , 2010, Mitochondrion.

[3]  Shing-Hwa Liu,et al.  Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. , 2010, Cancer letters.

[4]  J. Neuzil,et al.  Lyophilised liposome-based formulations of alpha-tocopheryl succinate: preparation and physico-chemical characterisation. , 2010, Journal of pharmaceutical sciences.

[5]  A. Kong,et al.  Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM. , 2010, Carcinogenesis.

[6]  G. Sudhandiran,et al.  Curcumin prevents free radical-mediated cataractogenesis through modulations in lens calcium. , 2010, Free radical biology & medicine.

[7]  R. Moreno-Sánchez,et al.  Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. , 2010, Molecular aspects of medicine.

[8]  H. Groen,et al.  TRAIL receptor targeting therapies for non-small cell lung cancer: current status and perspectives. , 2010, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[9]  Peng Huang,et al.  Small mitochondria-targeting molecules as anti-cancer agents. , 2010, Molecular aspects of medicine.

[10]  Divya Pathania,et al.  Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. , 2009, Advanced drug delivery reviews.

[11]  M. Niso-Santano,et al.  Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species. , 2009, Neurotoxicology.

[12]  Alexis A. Jourdain,et al.  Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. , 2009, The international journal of biochemistry & cell biology.

[13]  Min Young Kim,et al.  Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. , 2009, Anticancer research.

[14]  Y. Hiraku,et al.  Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant-antioxidant status in hamsters infected with Opisthorchis viverrini. , 2009, Molecular nutrition & food research.

[15]  N. Chandel,et al.  Mitochondrial Metabolism and Cancer , 2009, Annals of the New York Academy of Sciences.

[16]  Sean Davis,et al.  Analyses of Resected Human Brain Metastases of Breast Cancer Reveal the Association between Up-Regulation of Hexokinase 2 and Poor Prognosis , 2009, Molecular Cancer Research.

[17]  Deborah A. Bowen,et al.  Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  S. Mariotto,et al.  Involvement of mitochondrial permeability transition pore opening in α‐bisabolol induced apoptosis , 2009, The FEBS journal.

[19]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[20]  J. Arbiser,et al.  Honokiol-mediated Inhibition of PI3K/mTOR Pathway: A Potential Strategy to Overcome Immunoresistance in Glioma, Breast, and Prostate Carcinoma Without Impacting T Cell Function , 2009, Journal of immunotherapy.

[21]  Jaroslav Turánek,et al.  Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice. , 2009, Toxicology and applied pharmacology.

[22]  Bipul R. Acharya,et al.  Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity. , 2009, Biochemistry.

[23]  F. Khuri,et al.  Perspectives for cancer prevention with natural compounds. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  A. Halestrap.  What is the mitochondrial permeability transition pore? , 2009, Journal of molecular and cellular cardiology.

[25]  G. Pani,et al.  The p53-p66shc-Manganese Superoxide Dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species. , 2009, The international journal of biochemistry & cell biology.

[26]  J. Arbiser,et al.  Honokiol, a multifunctional antiangiogenic and antitumor agent. , 2009, Antioxidants & redox signaling.

[27]  Hui Zhang,et al.  Redox regulation and its emerging roles in stem cells and stem-like cancer cells. , 2009, Antioxidants & redox signaling.

[28]  J. Ajani,et al.  Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol. , 2009, Antioxidants & redox signaling.

[29]  R. Moreno-Sánchez,et al.  Suppression of Tumor Growth In vivo by the Mitocan α-tocopheryl Succinate Requires Respiratory Complex II , 2009, Clinical Cancer Research.

[30]  D. Linseman,et al.  Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. , 2009, Antioxidants & redox signaling.

[31]  Y. Shukla,et al.  Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells. , 2008, Biochemical and biophysical research communications.

[32]  Faisal T Thayyullathil,et al.  Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase-dependent and -independent apoptosis in L929 cells. , 2008, Free radical biology & medicine.

[33]  Haiyang Xie,et al.  Involvement of p38 mitogen‐activated protein kinase pathway in honokiol‐induced apoptosis in a human hepatoma cell line (hepG2) , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[34]  P. Pedersen.  Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment’s roles together with hexokinase-2 in the “Warburg effect” in cancer , 2008, Journal of bioenergetics and biomembranes.

[35]  K. Possinger,et al.  Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. , 2008, European journal of pharmacology.

[36]  F. Khuri,et al.  Synergistic inhibition of head and neck tumor growth by green tea (−)‐epigallocatechin‐3‐gallate and EGFR tyrosine kinase inhibitor , 2008, International journal of cancer.

[37]  W. Plunkett,et al.  Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. , 2008, Blood.

[38]  K. Brown,et al.  Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated with isothiocyanates. , 2008, Free radical biology & medicine.

[39]  T. Kamata,et al.  NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression , 2008, Oncogene.

[40]  Peng Huang,et al.  Redox regulation of cell survival. , 2008, Antioxidants & redox signaling.

[41]  T. Cotter,et al.  Mechanisms of ROS modulated cell survival during carcinogenesis. , 2008, Cancer letters.

[42]  M. Ushio-Fukai,et al.  Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. , 2008, Cancer letters.

[43]  M. Nishikawa.  Reactive oxygen species in tumor metastasis. , 2008, Cancer letters.

[44]  F. Domann,et al.  α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II , 2008, Oncogene.

[45]  D. Bar-Sagi,et al.  Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer Cells , 2008, Clinical Cancer Research.

[46]  K. Tsai,et al.  Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. , 2008, Free radical biology & medicine.

[47]  H. Daniel,et al.  Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. , 2008, Journal of agricultural and food chemistry.

[48]  G. Chainy,et al.  Alleviation of enhanced oxidative stress and oxygen consumption of L-thyroxine induced hyperthyroid rat liver mitochondria by vitamin E and curcumin. , 2008, Chemico-biological interactions.

[49]  J. Hayashi,et al.  ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.

[50]  K. Sugimura,et al.  DNA polymerase γ inhibition by vitamin K3 induces mitochondria‐mediated cytotoxicity in human cancer cells , 2008, Cancer science.

[51]  Nobuyuki Tanaka,et al.  p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation , 2008, Nature Cell Biology.

[52]  C. Graham,et al.  Chemosensitization of cancer by nitric oxide. , 2008, Current pharmaceutical design.

[53]  Yuquan Wei,et al.  Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer , 2008, Journal of Cancer Research and Clinical Oncology.

[54]  R. Meacham,et al.  Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. , 2008, Cancer research.

[55]  J. McNulty,et al.  Synergy of pancratistatin and tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria , 2008, Cancer biology & therapy.

[56]  S. Ray.  Synergy of pancratistatin and tamoxifen in inducing apoptosis in breast cancer cells , 2008, Cancer biology & therapy.

[57]  P. Cooper,et al.  Sodium pancratistatin 3,4-o-cyclic phosphate, a water-soluble synthetic derivative of pancratistatin, is highly effective in a human colon tumor model. , 2008, Journal of natural products.

[58]  Peng Liu,et al.  A total synthesis of OSW-1. , 2008, The Journal of organic chemistry.

[59]  R. Rawal,et al.  Lipid Peroxidation, Total Antioxidant Status, and Total Thiol Levels Predict Overall Survival in Patients With Oral Squamous Cell Carcinoma , 2007, Integrative cancer therapies.

[60]  G. Filomeni,et al.  trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways , 2007, Genes & Nutrition.

[61]  Jun O. Liu,et al.  Synthesis of the A,B-ring-truncated OSW saponin analogs and their antitumor activities. , 2007, Bioorganic & medicinal chemistry letters.

[62]  Shivendra V. Singh,et al.  Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity , 2007, Molecular Cancer Therapeutics.

[63]  Xiu-fang Wang,et al.  Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. , 2007, Molecular aspects of medicine.

[64]  B. Lefkove,et al.  Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. , 2007, Bioorganic & medicinal chemistry letters.

[65]  J. Arbiser,et al.  Honokiol, a Natural Plant Product, Inhibits Inflammatory Signals and Alleviates Inflammatory Arthritis1 , 2007, The Journal of Immunology.

[66]  M. Strnad,et al.  New analogues of the potent cytotoxic saponin OSW-1. , 2007, Journal of medicinal chemistry.

[67]  T. Veenstra,et al.  The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. , 2007, Cancer research.

[68]  G. Semenza,et al.  HIF-1 mediates the Warburg effect in clear cell renal carcinoma , 2007, Journal of bioenergetics and biomembranes.

[69]  Jianhong Luo,et al.  Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. , 2007, Cancer research.

[70]  T. Honda,et al.  Analysis of antitumor active OSW-1 and its analogues by liquid chromatography coupled with electrospray and atmospheric pressure chemical ionization quadrupole mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.

[71]  B. Aggarwal,et al.  Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. , 2007, Cancer research.

[72]  Jun O. Liu,et al.  Synthesis of OSW saponin analogs with modified sugar residues and their antiproliferative activities. , 2007, Bioorganic & medicinal chemistry letters.

[73]  Xiu-fang Wang,et al.  Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II , 2007, Journal of bioenergetics and biomembranes.

[74]  H. Majima,et al.  Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. , 2007, Mitochondrion.

[75]  F. Meyskens,et al.  UC Irvine UC Irvine Previously Published Works Title Reactive oxygen species : a breath of life or death ? , 2007 .

[76]  Wen-Sheng Wu.  The signaling mechanism of ROS in tumor progression , 2007, Cancer and Metastasis Reviews.

[77]  C. Chinopoulos,et al.  Bioenergetics and the formation of mitochondrial reactive oxygen species. , 2006, Trends in pharmacological sciences.

[78]  E. Tiligada.  Chemotherapy: induction of stress responses. , 2006, Endocrine-related cancer.

[79]  W. Morgan,et al.  Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review. , 2006, Mutagenesis.

[80]  Xiu-fang Wang,et al.  Molecular mechanism of ‘mitocan’‐induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl‐2 family proteins , 2006, FEBS letters.

[81]  N. Swamy,et al.  Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. , 2006, Gynecologic oncology.

[82]  P. Schumacker,et al.  Reactive oxygen species in cancer cells: live by the sword, die by the sword. , 2006, Cancer cell.

[83]  Jinsong Liu,et al.  Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.

[84]  M. Kumar,et al.  High dose vitamin K3 infusion in advanced hepatocellular carcinoma , 2006, Journal of gastroenterology and hepatology.

[85]  H. Pelicano,et al.  Glycolysis inhibition for anticancer treatment , 2006, Oncogene.

[86]  Marty C. Brandon,et al.  Mitochondrial mutations in cancer , 2006, Oncogene.

[87]  A. Kong,et al.  Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2 , 2006, Molecular Cancer Therapeutics.

[88]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[89]  Oksana Gavrilova,et al.  p53 Regulates Mitochondrial Respiration , 2006, Science.

[90]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[91]  T. Shanafelt,et al.  Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. , 2006, Leukemia research.

[92]  A. Khar,et al.  Biological effects of curcumin and its role in cancer chemoprevention and therapy. , 2006, Anti-cancer agents in medicinal chemistry.

[93]  M. Pillai,et al.  Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP‐1 translocation, and modulation of apoptosis , 2006, Molecular carcinogenesis.

[94]  G. Evan,et al.  Glucose Withdrawal Induces Oxidative Stress followed by Apoptosis in Glioblastoma Cells but not in Normal Human Astrocytes , 2006, Molecular Cancer Research.

[95]  K. Arihiro,et al.  Regulation and interplay of apoptotic and non‐apoptotic cell death , 2006, The Journal of pathology.

[96]  Angel Ortega,et al.  Glutathione in Cancer Biology and Therapy , 2006, Critical reviews in clinical laboratory sciences.

[97]  Z. Estrov,et al.  OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action. , 2005, Journal of the National Cancer Institute.

[98]  Lei Xiong,et al.  Apoptosis Induced by a New Member of Saponin Family Is Mediated through Caspase-8-Dependent Cleavage of Bcl-2 , 2005, Molecular Pharmacology.

[99]  H. Pelicano,et al.  Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells , 2005, Leukemia.

[100]  Chi-Keung Wan,et al.  Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation , 2005 .

[101]  Eyal Gottlieb,et al.  Mitochondrial tumour suppressors: a genetic and biochemical update , 2005, Nature Reviews Cancer.

[102]  G. Achanta,et al.  Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ , 2005, The EMBO journal.

[103]  Chun-ching Lin,et al.  Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells. , 2005, European journal of pharmacology.

[104]  Keisuke Ito,et al.  Green Tea Component, Catechin, Induces Apoptosis of Human Malignant B Cells via Production of Reactive Oxygen Species , 2005, Clinical Cancer Research.

[105]  S. Lowe,et al.  Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants , 2005, Nature.

[106]  S. Korsmeyer,et al.  Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[107]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[108]  T. Hurd,et al.  Glutathionylation of mitochondrial proteins. , 2005, Antioxidants & redox signaling.

[109]  S. Sen,et al.  Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. , 2005, Biochemical and biophysical research communications.

[110]  J. Doroshow,et al.  Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy , 2005, Investigational New Drugs.

[111]  J. McNulty,et al.  Pancratistatin: A natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis , 2005, Apoptosis.

[112]  S. Haldar,et al.  Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. , 2005, Carcinogenesis.

[113]  H. Mukhtar,et al.  Anti‐proliferative and proapoptotic effects of (−)‐epigallocatechin‐3‐gallate on human melanoma: Possible implications for the chemoprevention of melanoma , 2005, International journal of cancer.

[114]  R. Gillies,et al.  Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors , 2005 .

[115]  M. Wyss,et al.  Elevated creatine kinase activity in primary hepatocellular carcinoma , 2005, BMC gastroenterology.

[116]  S. Katiyar,et al.  Growth Inhibitory and Antimetastatic Effect of Green Tea Polyphenols on Metastasis-Specific Mouse Mammary Carcinoma 4T1 Cells In vitro and In vivo Systems , 2005, Clinical Cancer Research.

[117]  P. Zhou,et al.  Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo , 2005, British journal of haematology.

[118]  J. McNulty,et al.  Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells , 2005, Cancer Chemotherapy and Pharmacology.

[119]  S. Lowe,et al.  A conserved element in Myc that negatively regulates its proapoptotic activity , 2005, EMBO reports.

[120]  J. McNulty,et al.  Induction of Apoptotic Cell Death Specifically in Rat and Human Cancer Cells by Pancratistatin , 2005, Artificial cells, blood substitutes, and immobilization biotechnology.

[121]  Tao Wang,et al.  Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. , 2004, World journal of gastroenterology.

[122]  K. Greulich,et al.  Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. , 2004, Genomics.

[123]  K. Anderson,et al.  Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. , 2004, Blood.

[124]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[125]  Chao-yuan Huang,et al.  Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide , 2004, Anti-cancer drugs.

[126]  Kun-Young Park,et al.  Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. , 2004, Journal of medicinal food.

[127]  A. Villunger,et al.  The Bcl-2 protein family and its role in the development of neoplastic disease , 2004, Experimental Gerontology.

[128]  A. Alavi,et al.  Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.

[129]  S. Pervaiz,et al.  Tumor intracellular redox status and drug resistance--serendipity or a causal relationship? , 2004, Current pharmaceutical design.

[130]  Ken Itoh,et al.  Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. , 2004, Free radical biology & medicine.

[131]  M. Armoni,et al.  The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression , 2004, Cancer Research.

[132]  L. Behrend,et al.  Reactive oxygen species in oncogenic transformation. , 2003, Biochemical Society transactions.

[133]  M. Morris,et al.  Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatography-tandem mass spectrometry. , 2003, Analytical biochemistry.

[134]  R. Béliveau,et al.  Medulloblastoma cell invasion is inhibited by green tea (−)epigallocatechin‐3‐gallate , 2003, Journal of cellular biochemistry.

[135]  R. Cetin-Atalay,et al.  Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism? , 2003, Cancer research.

[136]  D. Dickinson,et al.  Green Tea Polyphenol Causes Differential Oxidative Environments in Tumor versus Normal Epithelial Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[137]  L. Tang,et al.  Selected isothiocyanates rapidly induce growth inhibition of cancer cells. , 2003, Molecular cancer therapeutics.

[138]  W. Plunkett,et al.  Inhibition of Mitochondrial Respiration , 2003, Journal of Biological Chemistry.

[139]  A. Kong,et al.  Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. , 2003, Carcinogenesis.

[140]  A. Kong,et al.  The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. , 2003, Carcinogenesis.

[141]  Peng Huang,et al.  Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications , 2003, Leukemia.

[142]  B. Halliwell,et al.  β-phenylethyl isothiocyanate-mediated apoptosis in hepatoma HepG2 cells , 2003, Cellular and Molecular Life Sciences CMLS.

[143]  A. Porter,et al.  Green tea polyphenol targets the mitochondria in tumor cells inducing caspase 3-dependent apoptosis. , 2003, Anticancer research.

[144]  M. Sharief,et al.  Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis , 2003, Journal of Neuroimmunology.

[145]  S. Gambhir.  Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[146]  Huasheng Lu,et al.  Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis* , 2002, The Journal of Biological Chemistry.

[147]  T. Tsai,et al.  Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells. , 2002, Biochemical pharmacology.

[148]  P. Pedersen,et al.  Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. , 2001, Cancer letters.

[149]  Z. Miao,et al.  Synthesis of OSW-1 analogues and a dimer and their antitumor activities. , 2001, Bioorganic & medicinal chemistry letters.

[150]  S. Bonhoeffer,et al.  Cooperation and Competition in the Evolution of ATP-Producing Pathways , 2001, Science.

[151]  S. Hecht,et al.  High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate. , 2001, Analytical biochemistry.

[152]  Paul J Thornalley,et al.  Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro. , 2001, Biochemical pharmacology.

[153]  D. Xiao,et al.  Synthesis of glycosides bearing the disaccharide of OSW-1 or its 1-->4-linked analogue and their antitumor activities. , 2000, Carbohydrate research.

[154]  Peng Huang,et al.  Superoxide dismutase as a target for the selective killing of cancer cells , 2000, Nature.

[155]  C. Dang,et al.  Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.

[156]  S. Hecht,et al.  Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. , 1999, The Journal of nutrition.

[157]  C. Guo,et al.  On the relationship of OSW-1 to the cephalostatins. , 1999, Bioorganic & medicinal chemistry letters.

[158]  Biao Yu,et al.  First Total Synthesis of an Exceptionally Potent Antitumor Saponin, OSW-1. , 1999, The Journal of organic chemistry.

[159]  Y. Higashi,et al.  Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients , 1998, Japanese journal of cancer research : Gann.

[160]  John Calvin Reed.  Molecular biology of chronic lymphocytic leukemia. , 1998, Seminars in oncology.

[161]  K. Nakachi,et al.  Cancer-preventive effects of drinking green tea among a Japanese population. , 1997, Preventive medicine.

[162]  Saroj P. Mathupala,et al.  Glucose Catabolism in Cancer Cells , 1997, The Journal of Biological Chemistry.

[163]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[164]  J. Zweier,et al.  Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts , 1997, Science.

[165]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[166]  T. Tsai,et al.  Pharmacokinetics of honokiol after intravenous administration in rats assessed using high-performance liquid chromatography. , 1994, Journal of chromatography. B, Biomedical applications.

[167]  P. Talalay,et al.  Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. , 1994, Cancer research.

[168]  V. Prasad,et al.  Interaction of dolastatin 10 with bovine brain tubulin. , 1992, Biochemical pharmacology.

[169]  K. H. Chi,et al.  Menadione-induced DNA damage in a human tumor cell line. , 1991, Biochemical pharmacology.

[170]  A. Cheng,et al.  Menadione: spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines. , 1991, Biochemical pharmacology.

[171]  C. Nathan,et al.  Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.

[172]  H. Lodish,et al.  Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.

[173]  R. Kuttan,et al.  Turmeric and Curcumin as Topical Agents in Cancer Therapy , 1987, Tumori.

[174]  J. Gold.  In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals. , 1986, Cancer treatment reports.

[175]  R. Kuttan,et al.  Potential anticancer activity of turmeric (Curcuma longa). , 1985, Cancer letters.

[176]  R. Chlebowski,et al.  Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation. , 1985, Cancer treatment reports.

[177]  D. D. Di Monte,et al.  Alterations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes. , 1984, Archives of biochemistry and biophysics.

[178]  G. Cragg,et al.  Antineoplastic agents, 105. Zephyranthes grandiflora. , 1984, Journal of natural products.

[179]  K. Prasad,et al.  Vitamin K3 (menadione) inhibits the growth of mammalian tumor cells in culture. , 1981, Life sciences.

[180]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[181]  D. Wallace,et al.  Energetics, epigenetics, mitochondrial genetics. , 2010, Mitochondrion.

[182]  J. Neuzil,et al.  Mitochondria as targets for cancer therapy. , 2009, Molecular nutrition & food research.

[183]  Jun Xie,et al.  Proteomics-based approach to elucidate the mechanism of antitumor effect of curcumin in cervical cancer. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[184]  Alfons Lawen,et al.  Targeting mitochondrial permeability in cancer drug development. , 2009, Molecular nutrition & food research.

[185]  D. Ross,et al.  Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells , 2009, Cancer Chemotherapy and Pharmacology.

[186]  Yan Zhao,et al.  Vitamin E analogues as mitochondria-targeting compounds: from the bench to the bedside? , 2009, Molecular nutrition & food research.

[187]  M. Baraldi,et al.  Peripheral benzodiazepine receptor (PBR) new insight in cell proliferation and cell differentiation review. , 2008, Current clinical pharmacology.

[188]  P. Huang,et al.  Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism , 2008, Leukemia.

[189]  Y. Shukla,et al.  Chemopreventive Potential of Resveratrol in Mouse Skin Tumors Through Regulation of Mitochondrial and PI3K/AKT Signaling Pathways , 2008, Pharmaceutical Research.

[190]  C. Knudson,et al.  Mitochondria potential, bax "activation," and programmed cell death. , 2008, Methods in molecular biology.

[191]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[192]  Lorenzo Galluzzi,et al.  Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.

[193]  Juan F. García,et al.  Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. , 2007, Blood.

[194]  L. Tang,et al.  Cancer-preventive isothiocyanates: dichotomous modulators of oxidative stress. , 2005, Free radical biology & medicine.

[195]  Andy H. Lee,et al.  Protective effect of green tea against prostate cancer: A case‐control study in southeast China , 2004, International journal of cancer.

[196]  Park S. Nobel,et al.  Summary and Future Perspectives , 2004 .

[197]  J. Tillement,et al.  Effects of resveratrol on the rat brain respiratory chain. , 1999, Drugs under experimental and clinical research.

[198]  A. Meister.  Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. , 1991, Pharmacology & therapeutics.